Previous close | 3.4000 |
Open | 5.0000 |
Bid | 4.4500 |
Ask | 5.7500 |
Strike | 134.00 |
Expiry date | 2024-05-17 |
Day's range | 5.0000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
RAHWAY, N.J., May 13, 2024--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma
By buying an index fund, investors can approximate the average market return. But if you pick the right individual...
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.